About   Help   FAQ
Phenotypes Associated with This Genotype
Genotype
MGI:5295749
Allelic
Composition
Lmnatm1.1Otin/Lmnatm1.1Otin
Genetic
Background
involves: 129P2/OlaHsd * C57BL/6
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Lmnatm1.1Otin mutation (0 available); any Lmna mutation (84 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging
• mutants exhibit an average lifespan of 103 days (J:177632)
• mutants exhibit premature aging as indicated by an increase in senescence-associated beta-galactosidase staining in the liver and kidney at 3 months of age

growth/size/body
• smaller lower incisors
• mutants exhibit progressive weight loss after 3 weeks of age
• mutants show reduced growth rates after 3 weeks of age, with progressive weight loss

reproductive system

cardiovascular system
• seen in 10 week old mice
• treatment with intraperitoneal injections of pyrophosphate over 9 weeks inhibits aortic calcification
• mutants exhibit loss of vascular smooth muscle cells in the aortic arch, but not in the medial layer of the thoracic aorta
• blood pressure appears normal but mutants progressively develop bradycardia between 9 and 15 weeks of age
• ECG indicates prolonged QRS waves without changes in the PR interval, indicating altered heart ventricular depolarization
• however, no differences in systolic function or diastolic function are seen

cellular
• mutants show nuclear abnormalities due to progerin accumulation (J:177632)
• 81% of cultured fibroblasts at passage 5 contain large and abnormally shaped nuclei (J:177632)
• MEFs have more misshapen nuclei with nuclear blebs than wild-type MEFs (J:177575)
• 81% of cultured fibroblasts at passage 5 contain large and abnormally shaped nuclei with foci highly stained with anti-gammaH2AX antibodies, indicating genotoxic stress

craniofacial
• skulls are reduced in size
• smaller lower incisors

adipose tissue
• older mutants exhibit a generalized loss of principal fat deposits, with a loss of the subcutaneous fat layer

homeostasis/metabolism
• mutants show a decrease in serum levels of insulin-like factor 1
• at 2 months of age, mutants show a decrease in serum glucose concentrations that leads to extreme hypoglycemia by 3 months of age

immune system
• thymus exhibits a marked involution relative to wild-type mice, even after accounting for body size differences
• spleen exhibits a marked involution relative to wild-type mice, even after accounting for body size differences

integument
• older mutants exhibit a generalized loss of principal fat deposits, with a loss of the subcutaneous fat layer
• older mutants exhibit attrition of hair follicles

behavior/neurological

muscle
• mutants exhibit loss of vascular smooth muscle cells in the aortic arch, but not in the medial layer of the thoracic aorta

hematopoietic system
• thymus exhibits a marked involution relative to wild-type mice, even after accounting for body size differences
• spleen exhibits a marked involution relative to wild-type mice, even after accounting for body size differences

skeleton
• skulls are reduced in size
• smaller lower incisors
• mutants develop cervicothoracic lordokyphosis
• tibias exhibit increased porosity
• tibias exhibit reduced bone density
• bone volume of tibias is decreased
• tibias exhibit reduced cortical thickness

endocrine/exocrine glands
• thymus exhibits a marked involution relative to wild-type mice, even after accounting for body size differences

Mouse Models of Human Disease
DO ID OMIM ID(s) Ref(s)
progeria DOID:3911 OMIM:176670
J:177575 , J:177632 , J:211388


Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
11/12/2024
MGI 6.24
The Jackson Laboratory